Successful Treatment of Linear Psoriasis With the IL-17a-Antagonist Ixekizumab: A Case Report
Slatina Christov, Frenz Ohm, Matthias Augustin, Jan Nicolai Wagner Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), 20246 Hamburg, GermanyCorrespondence: Jan Nicolai Wagner, Institute for Health Services Research in Dermatol...
Saved in:
Main Authors: | Christov S, Ohm F, Augustin M, Wagner JN |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-01-01
|
Series: | Psoriasis: Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/successful-treatment-of-linear-psoriasis-with-the-il-17a-antagonist-ix-peer-reviewed-fulltext-article-PTT |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of The Impact of Apremilast on Levels of IL-17, IL-23, and Lipids in Obese Psoriatic Patient
by: Haitham M. Saad, et al.
Published: (2024-12-01) -
Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study – IL PSO (Italian landscape psoriasis)
by: Mario Valenti, et al.
Published: (2025-12-01) -
Pregnancy outcomes in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis receiving ixekizumab
by: A. Egeberg, et al.
Published: (2022-07-01) -
Long-Term Safety of Ixekizumab Treatment in Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: a Post Hoc Analysis of Cerebro-Cardiovascular Events
by: Mark Lebwohl, et al.
Published: (2025-01-01) -
Deciphering the role of IL17RA in psoriasis and chronic mucocutaneous candidiasis: shared pathways and distinct manifestations
by: Ayat Kadhi, et al.
Published: (2025-01-01)